GW 610 (NSC 721648) is primarily researched for its potential in cancer therapy. It has shown promise in inhibiting specific pathways involved in tumor growth, making it a candidate for targeted cancer treatments. Studies focus on its ability to interfere with cellular mechanisms that promote cancer cell survival, potentially leading to the development of novel anticancer drugs. Additionally, it is being explored for its role in overcoming drug resistance in certain cancers, which could enhance the effectiveness of existing therapies. Research is ongoing to fully understand its therapeutic potential and safety profile.